Benzinga's Top Upgrades, Downgrades For September 11, 2020
Upgrades
According to Wedbush, the prior rating for Sage Therapeutics Inc (NASDAQ: SAGE) was changed from Neutral to Outperform. Sage Therapeutics earned $2.08 in the second quarter, compared to $3.28 in the year-ago quarter. The current stock performance of Sage Therapeutics shows a 52-week-high of $167.82 and a 52-week-low of $25.01. Moreover, at the end of the last trading period, the closing price was at $54.25.
According to Stifel, the prior rating for Photronics Inc (NASDAQ: PLAB) was changed from Hold to Buy. For the third quarter, Photronics had an EPS of $0.17, compared to year-ago quarter EPS of $0.10. At the moment, the stock has a 52-week-high of $16.75 and a 52-week-low of $8.31. Photronics closed at $8.73 at the end of the last trading period.
For ACM Research Inc (NASDAQ: ACMR), Stifel upgraded the previous rating of Hold to the current rating Buy. ACM Research earned $0.29 in the second quarter, compared to $0.26 in the year-ago quarter. The current stock performance of ACM Research shows a 52-week-high of $113.87 and a 52-week-low of $12.51. Moreover, at the end of the last trading period, the closing price was at $60.66.
Cowen & Co. upgraded the previous rating for Adobe Inc (NASDAQ: ADBE) from Market Perform to Outperform. In the second quarter, Adobe showed an EPS of $2.45, compared to $1.83 from the year-ago quarter. The stock has a 52-week-high of $536.88 and a 52-week-low of $255.13. At the end of the last trading period, Adobe closed at $476.26.
According to Needham, the prior rating for PerkinElmer Inc (NYSE: PKI) was changed from Hold to Buy. For the second quarter, PerkinElmer had an EPS of $1.57, compared to year-ago quarter EPS of $1.00. The current stock performance of PerkinElmer shows a 52-week-high of $123.21 and a 52-week-low of $62.91. Moreover, at the end of the last trading period, the closing price was at $113.39.
Baird upgraded the previous rating for SunPower Corp (NASDAQ: SPWR) from Neutral to Outperform. In the second quarter, SunPower showed an EPS of $0.22, compared to $0.22 from the year-ago quarter. The current stock performance of SunPower shows a 52-week-high of $15.57 and a 52-week-low of $4.03. Moreover, at the end of the last trading period, the closing price was at $10.66.
According to Cowen & Co., the prior rating for Domino's Pizza Inc (NYSE: DPZ) was changed from Market Perform to Outperform. In the second quarter, Domino's Pizza showed an EPS of $2.99, compared to $2.19 from the year-ago quarter. The current stock performance of Domino's Pizza shows a 52-week-high of $424.72 and a 52-week-low of $227.50. Moreover, at the end of the last trading period, the closing price was at $389.25.
For LyondellBasell Industries NV (NYSE: LYB), JP Morgan upgraded the previous rating of Neutral to the current rating Overweight. For the second quarter, LyondellBasell Industries had an EPS of $0.68, compared to year-ago quarter EPS of $2.70. At the moment, the stock has a 52-week-high of $98.91 and a 52-week-low of $33.71. LyondellBasell Industries closed at $70.91 at the end of the last trading period.
Downgrades
According to Wedbush, the prior rating for Virtusa Corp (NASDAQ: VRTU) was changed from Outperform to Neutral. Virtusa earned $0.20 in the first quarter, compared to $0.41 in the year-ago quarter. At the moment, the stock has a 52-week-high of $52.81 and a 52-week-low of $19.48. Virtusa closed at $50.42 at the end of the last trading period.
For Satsuma Pharmaceuticals Inc (NASDAQ: STSA), Mizuho downgraded the previous rating of Buy to the current rating Neutral. In the second quarter, Satsuma Pharmaceuticals earned $0.65. The stock has a 52-week-high of $36.10 and a 52-week-low of $4.55. At the end of the last trading period, Satsuma Pharmaceuticals closed at $5.62.
For Satsuma Pharmaceuticals Inc (NASDAQ: STSA), Credit Suisse downgraded the previous rating of Outperform to the current rating Underperform. In the second quarter, Satsuma Pharmaceuticals earned $0.65. At the moment, the stock has a 52-week-high of $36.10 and a 52-week-low of $4.55. Satsuma Pharmaceuticals closed at $5.62 at the end of the last trading period.
Initiations
Truist Securities initiated coverage on Select Interior Concepts Inc (NASDAQ: SIC) with a Buy rating. The price target for Select Interior Concepts is set to $10.00. In the second quarter, Select Interior Concepts showed an EPS of $0.13, compared to $0.08 from the year-ago quarter. At the moment, the stock has a 52-week-high of $13.76 and a 52-week-low of $1.25. Select Interior Concepts closed at $6.32 at the end of the last trading period.
With a current rating of Buy, BTIG initiated coverage on Redhill Biopharma Ltd (NASDAQ: RDHL). The price target seems to have been set at $26.00 for Redhill Biopharma. For the second quarter, Redhill Biopharma had an EPS of $0.04, compared to year-ago quarter EPS of $0.04. At the moment, the stock has a 52-week-high of $10.96 and a 52-week-low of $3.26. Redhill Biopharma closed at $10.16 at the end of the last trading period.
Berenberg initiated coverage on Cabot Microelectronics Corp (NASDAQ: CCMP) with a Hold rating. The price target for Cabot Microelectronics is set to $155.00. For the third quarter, Cabot Microelectronics had an EPS of $1.80, compared to year-ago quarter EPS of $1.59. The stock has a 52-week-high of $174.87 and a 52-week-low of $85.26. At the end of the last trading period, Cabot Microelectronics closed at $144.43.
Needham initiated coverage on BioTelemetry Inc (NASDAQ: BEAT) with a Buy rating. The price target for BioTelemetry is set to $52.00. In the second quarter, BioTelemetry showed an EPS of $0.35, compared to $0.53 from the year-ago quarter. At the moment, the stock has a 52-week-high of $55.85 and a 52-week-low of $27.35. BioTelemetry closed at $36.67 at the end of the last trading period.
For iRhythm Technologies Inc (NASDAQ: IRTC), Needham initiated coverage, by setting the current rating at Hold. iRhythm Technologies earned $0.75 in the second quarter, compared to $0.46 in the year-ago quarter. The current stock performance of iRhythm Technologies shows a 52-week-high of $232.58 and a 52-week-low of $56.24. Moreover, at the end of the last trading period, the closing price was at $211.10.
Rosenblatt initiated coverage on Skyworks Solutions Inc (NASDAQ: SWKS) with a Buy rating. The price target for Skyworks Solutions is set to $160.00. In the third quarter, Skyworks Solutions showed an EPS of $1.25, compared to $1.35 from the year-ago quarter. The current stock performance of Skyworks Solutions shows a 52-week-high of $154.24 and a 52-week-low of $67.90. Moreover, at the end of the last trading period, the closing price was at $135.23.
See more from Benzinga
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
